Počet záznamů: 1  

DEVELOPMENT OF LUMINEX XMAP BEAD-BASED IMMUNOASSAY FOR QUANTIFICATION OF MHTT

  1. 1.
    SYSNO ASEP0498970
    Druh ASEPA - Abstrakt
    Zařazení RIVO - Ostatní
    NázevDEVELOPMENT OF LUMINEX XMAP BEAD-BASED IMMUNOASSAY FOR QUANTIFICATION OF MHTT
    Tvůrce(i) Vodičková Kepková, Kateřina (UZFG-Y) ORCID
    Vodička, Petr (UZFG-Y) ORCID
    Zdroj.dok.Journal of Neurology Neurosurgery and Psychiatry - ISSN 0022-3050
    Roč. 89, S1 (2018), A33-A33
    Poč.str.1 s.
    AkcePlenary Meeting of the European Huntington´s Disease Network (EHDN)
    Datum konání14.09.2018 - 16.09.2018
    Místo konáníVienna
    ZeměAT - Rakousko
    Typ akceEUR
    Jazyk dok.eng - angličtina
    Země vyd.GB - Velká Británie
    Klíč. slovaluminex
    Vědní obor RIVEI - Biotechnologie a bionika
    Obor OECDTechnologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions (pharmacogenomics, gene-based therapeutics)
    CEPLO1609 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaUZFG-Y - RVO:67985904
    UT WOS000446126000090
    DOI10.1136/jnnp-2018-EHDN.89
    AnotaceHuntington’s disease is a fatal neurodegeneration caused by an expansion of CAG repeat in the huntingtin (HTT) gene. This repeat encodes prolonged stretch of glutamines near the N-terminus of HTT protein. Precise quantification of mutant huntingtin (mHTT) protein in the brain and biofluids, such as blood or cerebrospinal fluid (CSF), is needed as a potential biomarker of HD progression and for monitoring of therapeutic trials. Luminex xMAP technology allows for highly multiplexed (up to 100 analytes) bead-based sandwich immuno-assays, which could be advantageous for simultaneous analysis of mHTT together with other analytes in precious samples.
    We aimed to develop and verify Luminex xMAP assay for mHTT detection based on commercially available antibodies.
    We used the combination of N-terminal anti-HTT antibody EPR5526 (Abcam) conjugated to Luminex MagPlex microspheres as a capture and MW1 (DSHB) anti-polyQ antibody conjugated to biotin as a detection antibody to detect mHTT in brain samples of model species. Different amounts of brain tissue homogenate were incubated with EPR5526 conjugated microbeads, MW1 detection antibody and R-PE conjugated streptavidine and analyzed on Luminex xMAP 200 instrument. We were able to detect mHTT signal in all R6/2 mouse and TgHD minipig samples, with linear response to total protein load (R2=0.999 for TgHD samples, R2=0.981 for R6/2 samples). Signal in WT mouse and minipig samples was close to blank (buffer only) levels. Luminex xMAP bead-based sandwich assay with antibody pair EPR5526/MW1 detects mHTT in R6/2 mouse and TgHD minipig HD models and with further optimization could serve for mHTT quantification in tissue and body fluid samples.
    PracovištěÚstav živočišné fyziologie a genetiky
    KontaktJana Zásmětová, knihovna@iapg.cas.cz, Tel.: 315 639 554
    Rok sběru2019
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.